End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.02 AUD | -.--% | +5.26% | -.--% |
Apr. 30 | Transcript : Syntara Limited, Q3 2024 Earnings Call, Apr 30, 2024 | |
Apr. 10 | Syntara Reaches 50% Recruitment in Phase 2 Trial for Bone Marrow Cancer Treatment | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-.--% | 15.86M | |
+40.73% | 739B | |
+32.83% | 598B | |
-6.42% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.00% | 240B | |
-5.52% | 206B | |
+6.19% | 164B | |
-0.45% | 162B |
- Stock Market
- Equities
- SNT Stock
- News Syntara Limited
- Australian Bourse Halts Trading in Pharmaxis’ Securities